paromomycin has been researched along with Candidiasis in 4 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 1 (25.00) | 18.7374 |
| 1990's | 2 (50.00) | 18.2507 |
| 2000's | 1 (25.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| BHAT, KM; COLES, HM; HOLT, RJ; STEWART, GT | 1 |
| Auner, HW; Buzina, W; Krause, R; Ofner-Kopeinig, P; Olschewski, H; Paulitsch, A; Reisinger, EC; Staber, PB; Zollner-Schwetz, I | 1 |
| Gantenberg, R; Janda, J; Linss, G; Richter, C | 1 |
| Walker, MJ | 1 |
4 other study(ies) available for paromomycin and Candidiasis
| Article | Year |
|---|---|
REPLACEMENT COLIFORM FLORA IN CARRIERS OF INTESTINAL PATHOGENS.
Topics: Adolescent; Bacillus; Candidiasis; Carrier State; Child; Drug Resistance; Drug Resistance, Microbial; Dysentery; Dysentery, Bacillary; Escherichia coli; Humans; Infant; Infant, Newborn; Intestines; Neomycin; Paromomycin; Salmonella; Salmonella paratyphi A; Salmonella typhi; Salmonella typhimurium; Shigella; Streptomycin | 1964 |
Oral and intestinal Candida colonization in patients undergoing hematopoietic stem-cell transplantation.
Topics: Adult; Aged; Anti-Bacterial Agents; Candida albicans; Candidiasis; Carrier State; Female; Hematopoietic Stem Cell Transplantation; Humans; Immunocompromised Host; Intestines; Male; Middle Aged; Mouth; Paromomycin; Prevalence; Risk Factors; Vancomycin | 2008 |
[Leishmaniasis of the lips mimicking a mycotic infection].
Topics: Adult; Amebicides; Animals; Antimony Sodium Gluconate; Candidiasis; Diagnosis, Differential; Diagnostic Errors; Humans; Immunoglobulin E; Leishmania major; Leishmaniasis, Cutaneous; Lip Diseases; Male; Mouth Mucosa; Ointments; Paromomycin; Polymerase Chain Reaction | 1998 |
Opportunistic infections studies update.
Topics: AIDS-Related Opportunistic Infections; Amphotericin B; Antitubercular Agents; Atovaquone; Candidiasis; Clinical Trials as Topic; Cryptosporidiosis; Cytomegalovirus; Cytomegalovirus Infections; Ganciclovir; Humans; Immunotherapy; Mycobacterium avium-intracellulare Infection; Naphthoquinones; Paromomycin; Pneumonia, Pneumocystis; Pyrimethamine; Toxoplasmosis; Tuberculosis | 1995 |